Watchtower Advisors, LP
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 13, 2026), Watchtower Advisors, LP reported 11 stock positions worth $179.6 million. Its top holding was ASML Holding NV-NY Reg SHS (ASML) at 34.6% of the portfolio, followed by Omega Healthcare Investors (OHI, 14.4%) and CVS Health (CVS, 10.5%). Compared with Q1 2026, it opened 2 new positions, sold out of 3, added to 2 and reduced 2. The biggest buy was a new position in Textron (TXT) and the biggest sale an exit from Somnigroup International (SGI).
- Most Recent 13F
- Q2 2026
- Location
- OLD GREENWICH, CT
- CIK
- 0001807092
- Portfolio Value
- $179.6M (Q2 2026)
- SEC Filing
- 0001807092-26-000009 ↗ filed Aug 13, 2026
Holdings Value
Holdings 11 stocks · $179.6M
| ASML ASML Holding NV-NY Reg SHS filed as ASML HLDG NV | 34.63% | 31,261 | $62.2M | No change |
| OHI Omega Healthcare Investors | 14.37% | 541,138 | $25.8M | No change |
| CVS CVS Health Corp. | 10.50% | 182,357 | $18.9M | No change |
| MU Micron Technology Inc. | 7.71% | 12,000 | $13.9M | Reduce -47.9% |
| PATK Patrick Industries Inc. | 7.50% | 150,000 | $13.5M | No change |
| TXT Textron Inc. | 6.41% | 125,600 | $11.5M | New |
| SRE Sempra | 5.86% | 113,500 | $10.5M | Add +218.2% |
| IBP Installed Building Products | 4.13% | 32,277 | $7.4M | No change |
| NOK Nokia Corp.-Spon ADR | 3.70% | 500,000 | $6.6M | New |
| ELAN Elanco Animal Health Inc. | 3.04% | 221,725 | $5.5M | Add +50.0% |
| AMD Advanced Micro Devices | 2.16% | 6,666 | $3.9M | Reduce -83.3% |
Portfolio Sells Q1 2026 → Q2 2026
Portfolio Buys Q1 2026 → Q2 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 11 | $179.6M | ASML, OHI, CVS, MU, PATK |
| Q1 2026 | 12 | $141.0M | ASML, OHI, PATK, CVS, SGI |
| Q4 2025 | 11 | $165.6M | ASML, CVS, PATK, OHI, APH |
| Q3 2025 | 16 | $214.3M | CVS, ASML, RCL, CLH, APH |
| Q2 2025 | 18 | $168.9M | AXS, CVS, RCL, APPF, APH |
| Q1 2025 | 15 | $137.8M | AXS, CVS, HLT, RCL, VRNA |
| Q4 2024 | 14 | $176.7M | AXS, FTAI, HLT, ALLE, AVGO |
| Q3 2024 | 15 | $215.7M | AVGO, ACGL, HLT, AXS, FTAI |
| Q2 2024 | 11 | $155.1M | AVGO, ACGL, AXS, LII, MEDP |
| Q1 2024 | 13 | $180.2M | AVGO, LII, ACGL, MEDP, SPR |